Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Arvinas

Biotech & Life Sciences · New Haven, United States · Founded 2013 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue
$263M
Latest reported FY

Investors

13 investors on Arvinas's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
Elm Street Ventures
Connecticut Innovations
5AM Ventures
Canaan
Series B+ 9 investors entered at this stage
OrbiMed
Yale University
Hillhouse Capital
Sirona Capital
Nextech Venture
Deerfield
RA Capital Management
New Leaf Venture Partners
Nextech Invest

Global footprint

Where Arvinas has talent and traffic

AI talent share
0.7% of workforce is AI talent
(2 of 307 staff)
Core AI10.33%
Other AI10.33%
Non-AI workforce30599.35%
Web traffic by country
20K monthly visits
across markets
🇺🇸 United States51.5%
🇮🇳 India19.5%
🇬🇧 United Kingdom15%
🇨🇦 Canada7%
🇯🇵 Japan5.5%
Top 5 markets shown

Patent intelligence

$223M patent portfolio · 142 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$223M
3.5× smaller than top peer BioNTech ($780M)
142 active patent families
Where Arvinas innovates Molecular biologyTarget proteinDiseaseUbiquitin ligase bindingCereblon
Above peer median on Legal, Market

Quality vs same-sector peers

Arvinas on the five Patsnap quality dimensions

Arvinas in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Arvinas concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Arvinas and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Arvinas on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo